Metaxalone
NDC 50228-474, Metaxalone, tablet, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-474
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207466
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METAXALONE400 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-474-10 | 50228047410 | 1000 TABLET in 1 BOTTLE (50228-474-10) |
| 50228-474-30 | 50228047430 | 30 TABLET in 1 BOTTLE (50228-474-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1cef46bb-e590-4a58-82e0-7cf1fc3836a5
Use it
Look up 50228-474 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.